Zhihu in Quest to Be First Internet Firm with U.S., Hong Kong Primary Listings
The Q&A platform has applied for a second primary listing in Hong Kong, though reception for the deal has been tepid Key takeaways: Zhihu will make a second primary listing…
FAST NEWS: I-Mab to Move Ahead With Dual Listing in Hong Kong
The latest: U.S.-listed cancer drug developer I-Mab (IMAB.US) announced its board has approved a motion to pursue a listing on the Hong Kong Stock Exchange. The board also authorized the company's…
RELATED ARTICLES
-
After 14 years of losses, Zhihu finds an answer to its profitability question
2390.HK ZH.US - Hong Kong gains clout as preferred IPO watering hole for Chinese companies
-
CATL leads new charge of Mainland-listed companies into Hong Kong
300750.SHE
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
-
Xiaocaiyuan sets the table for Hong Kong IPO. But is the timing right?
0999.HK
- Youlife chases SPAC listing after death of Hong Kong IPO
